News & Updates

In the treatment of invasive infections due to multidrug-resistant P. aeruginosa, the use of ceftolozane–tazobactam combination appears to yield higher rates of clinical success than the ceftazidime–avibactam combination, according to an observational study.

Vaccination against human papillomavirus (HPV) among adults aged 27–45 years (mid-adults) is less cost-effective and generates a greater number needed to vaccinate (NNV) when compared with vaccination of persons aged 26 years and below, reports a study.

Researchers have found a new clade of Candida (C) auris, a multidrug-resistant fungal pathogen, in a genotypic and phenotypic study.

People living with HIV who have no history of hepatitis B virus (HBV) infection or documented response to vaccination appear to have a stronger immune response to the hepatitis B vaccine with a cytosine phosphoguanine adjuvant (HepB-CpG) than that with an aluminum hydroxide adjuvant (HepB-alum).

Patients with Takayasu arteritis (TA) who develop serious infections are susceptible to increased mortality, reveals a recent study.

In the AIRFLO study, treatment with ziresovir – a potent, selective, orally administered RSV F protein inhibitor – leads to a greater resolution of signs and symptoms of bronchiolitis in hospitalized infants and young children with respiratory syncytial virus (RSV) infection.

In individuals experiencing dyspnoea after sustaining a SARS-CoV-2 infection, physiotherapy, particularly pulmonary rehabilitation, may be beneficial in mitigating respiratory symptoms, according to the results of a systematic review and meta-analysis.

New research shows limited transmission of the rotavirus vaccine strains in neonatal intensive care units (NICUs), suggesting that the benefits of vaccination outweigh earlier concerns.